API Gallery
The Povidone-Iodine (PVP-Iodine) market is projected to grow at a CAGR of 5.6% from 2025 to 2035, driven by the continued global demand for broad-spectrum antiseptics in clinical, surgical, and consumer healthcare settings.
The Promethazine Hydrochloride market is projected to grow at a CAGR of 4.3% from 2025 to 2035, driven by its wide-ranging therapeutic use in allergy management, antiemetic therapy, and preoperative sedation.
The Carbimazole market is estimated to grow at a CAGR of 4.8% during the forecast period 2025-2035. The growth of the market is mainly inspired by the increasing prevalence of Graves’ disease, such as hyperthyroidism and related thyroid disorders. Carbimazole is a widely used anti-thyroid drug that is required to manage excessive thyroid hormone production and stabilize patients before thyroid surgery.
The global Pioglitazone API market is projected to grow at a CAGR of 5.1% during the forecast period, driven by its widespread application in the treatment of type 2 diabetes mellitus.
The Pitavastatin market is anticipated to grow at a CAGR of 5.3% between 2025 and 2035, driven by increasing incidences of cardiovascular disorders and the growing need for effective lipid-lowering therapies.
The Pitofenone market is projected to grow at a CAGR of 4.6% from 2025 to 2035, primarily driven by its widespread use in combination therapies for smooth muscle spasms and gastrointestinal disorders.
The Pitolisant Hydrochloride market is expected to register a CAGR of 6.7% from 2025 to 2035, propelled by rising global awareness and diagnosis of sleep disorders, especially narcolepsy and obstructive sleep apnea.
The Plazomicin market is projected to grow at a CAGR of 5.9% from 2025 to 2035, driven by the escalating global challenge of multidrug-resistant (MDR) bacterial infections.
The Carbinoxamine market is estimated to grow at a CAGR of 4.8% during the forecast period 2025-2035. The growth of the market is mainly inspired by the increasing demand for antihistamines used to treat allergic reactions, grass fever, and urticaria (hives).
The Plecanatide market is anticipated to grow at a CAGR of 6.3% between 2025 and 2035, fueled by the increasing prevalence of gastrointestinal disorders, particularly chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C).
The global Carbocisteine market is projected to grow at a CAGR of 5.8% during the forecast period 2025-2035. This growth is inspired by the increasing occurrence of chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), bronchitis, asthma and sinusitis.
The Global Carbocysteine Lysine Market is anticipated to grow at a CAGR of 5.8% during the forecast period 2025-2035, which is inspired by increasing adoption in the treatment of respiratory disorders such as chronic obstructive pulmonary disease (COPD), bronchitis and sinusitis.
The global Carbon market is projected to grow at a CAGR of 6.8% during the forecast period 2025-2035. This growth is mainly inspired by increasing adoption in drug formulation, especially in analgesics, anti-anti-inflammatory drugs and gastrointestinal medicines. Carbon, as a pharmaceutical drug including activated carbon, is widely used as an excipient in drug detoxification, poison treatment and controlled drug delivery systems.
The Plerixafor market is projected to grow at a CAGR of 7.1% between 2025 and 2035, driven by increasing use in stem cell mobilization and the treatment of hematologic cancers like multiple myeloma and non-Hodgkin lymphoma.
The global Carboplatin market is projected to grow at a CAGR of 5.8% during the forecast period 2025-2035. This growth is mainly driven by the increasing incidence of various cancers, including ovarian, lung, and testes cancer, and platinum-based chemotherapy razes.
Search from 10,000 + API reports
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
